Skip to main content
Equibles

Anthony Rimac

CFO

Sagimet Biosciences Inc. (SGMT)

Chief Accounting Officer

Sagimet Biosciences Inc. (SGMT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Anthony Rimac

Anthony Rimac is recorded as CFO and Chief Accounting Officer at Sagimet Biosciences Inc. (SGMT). Sagimet Biosciences Inc. reported in an 8-K filed February 2, 2024 that Anthony Rimac resigned as Chief Financial Officer, effective January 31, 2024. Sagimet Biosciences Inc. reported in an 8-K filed December 29, 2023 that Anthony Rimac resigned as Chief Financial Officer, effective January 31, 2024. Sagimet Biosciences Inc. reported in an 8-K filed July 27, 2023 that Anthony Rimac was appointed Chief Financial Officer, principal financial officer and principal accounting officer, effective August 1, 2023.

“on December 28, 2023, Anthony Rimac, the Chief Financial Officer of Sagimet Biosciences Inc. (the "Company") provided notice of his intent to resign effective January 31, 2024.”
Sagimet Biosciences Inc. Form 8-K, filed February 2, 2024 · Read the filing
“On December 28, 2023, Anthony Rimac provided notice of his intent to step down as the Chief Financial Officer of Sagimet Biosciences Inc. (the “Company”) effective January 31, 2024.”
Sagimet Biosciences Inc. Form 8-K, filed December 29, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Sagimet Biosciences Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.